<VariationArchive VariationID="2584417" VariationName="NM_000168.6(GLI3):c.3224del (p.Leu1075fs)" VariationType="Deletion" Accession="VCV002584417" Version="1" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-05-12" DateCreated="2023-10-21" MostRecentSubmission="2023-10-21">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="2751980" VariationID="2584417">
      <GeneList>
        <Gene Symbol="GLI3" FullName="GLI family zinc finger 3" GeneID="2737" HGNC_ID="HGNC:4319" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>7p14.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="7" Accession="NC_000007.14" start="41960949" stop="42264268" display_start="41960949" display_stop="42264268" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="7" Accession="NC_000007.13" start="42000546" stop="42276617" display_start="42000546" display_stop="42276617" Strand="-" />
          </Location>
          <OMIM>165240</OMIM>
          <Haploinsufficiency last_evaluated="2021-01-12" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=GLI3">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2021-01-12" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=GLI3">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_000168.6(GLI3):c.3224del (p.Leu1075fs)</Name>
      <CanonicalSPDI>NC_000007.14:41965848:A:</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>7p14.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="7" Accession="NC_000007.14" start="41965849" stop="41965849" display_start="41965849" display_stop="41965849" variantLength="1" positionVCF="41965848" referenceAlleleVCF="CA" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="7" Accession="NC_000007.13" start="42005447" stop="42005447" display_start="42005447" display_stop="42005447" variantLength="1" positionVCF="42005446" referenceAlleleVCF="CA" alternateAlleleVCF="C" />
      </Location>
      <ProteinChange>L1075fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000007.13" sequenceAccession="NC_000007" sequenceVersion="13" change="g.42005447del" Assembly="GRCh37">
            <Expression>NC_000007.13:g.42005447del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000007.14" sequenceAccession="NC_000007" sequenceVersion="14" change="g.41965849del" Assembly="GRCh38">
            <Expression>NC_000007.14:g.41965849del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008434.1" sequenceAccession="NG_008434" sequenceVersion="1" change="g.276172del">
            <Expression>NG_008434.1:g.276172del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008434.2" sequenceAccession="NG_008434" sequenceVersion="2" change="g.303419del">
            <Expression>NG_008434.2:g.303419del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000168.6" sequenceAccession="NM_000168" sequenceVersion="6" change="c.3224del" MANESelect="true">
            <Expression>NM_000168.6:c.3224del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000159.3" sequenceAccession="NP_000159" sequenceVersion="3" change="p.Leu1075fs">
            <Expression>NP_000159.3:p.Leu1075fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000168.6(GLI3):c.3224del (p.Leu1075fs) AND GLI3-related disorder" Accession="RCV003335857" Version="1">
        <ClassifiedConditionList TraitSetID="33757">
          <ClassifiedCondition DB="MedGen" ID="CN239292">GLI3-related disorder</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2023-10-21" MostRecentSubmission="2023-10-21">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="33757" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="36489" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">GLI3-Related Disorders</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">GLI3-related condition</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">GLI3-related disorder</ElementValue>
              </Name>
              <XRef ID="CN239292" DB="MedGen" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="7569747" SubmissionDate="2023-09-19" DateLastUpdated="2023-10-21" DateCreated="2023-10-21">
        <ClinVarSubmissionID localKey="NM_000168.5:c.3224del|GLI3-Related Disorders" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004046022" DateUpdated="2023-10-21" DateCreated="2023-10-21" Type="SCV" Version="1" SubmitterName="Rady Children's Institute for Genomic Medicine, Rady Children's Hospital San Diego" OrgID="506081" OrganizationCategory="laboratory" OrgAbbreviation="RCIGM" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>This frameshifting variant in exon 15 of 15 introduces a premature stop codon and is therefore predicted to result in loss of normal protein function through either protein truncation or nonsense-mediated mRNA decay (NMD). This variant has not been previously reported or functionally characterized in the literature to our knowledge. Loss-of-function variation in GLI3 is an established mechanism of disease (PMID: 20301638). It is absent from the gnomAD population database and thus is presumed to be rare. Analysis of the parental samples was negative for the variant, indicating this variant likely occurred as a de novo event. Based on the available evidence, the c.3224del (p.Leu1075ArgfsTer4) variant is classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="GLI3" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000168.5:c.3224del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">GLI3-Related Disorders</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13808474</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="7569747" TraitType="Disease" MappingType="Name" MappingValue="GLI3-Related Disorders" MappingRef="Preferred">
        <MedGen CUI="CN239292" Name="GLI3-related disorder" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

